Suvorexant-d6 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Suvorexant-d6 is the labeled analog of Suvorexant (S870000), a dual (non-selective) orexin receptor antagonist in development by Merck & Co. for the treatment of insomnia. It works by turning off wakefulness rather than by inducing sleep. Users of higher doses had an increased rate of suicidal ideation.

Suvorexant-d6 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Suvorexant-d6 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
SIMSON PHARMA LIMITED	+91-8291074273	k.das@simsonpharma.com	India	228	58
Nanjing Shizhou Biology Technology Co.,Ltd	17301488900	judy.xia@synzest.com	China	12582	58
TLC Pharmaceutical Standards Ltd.	18012923235; 18012923235	chinasales04@tlcstandards.com.cn	China	7407	58

---

• Suvorexant-d6
• C23H17D6ClN6O2